The increasing frequency of global health crises and stringent hygiene regulations are driving a critical need for advanced, sustainable disinfection technologies. Industries are under pressure to enhance public health safety while simultaneously optimizing operational efficiency and reducing reliance on manual labor. This power-free, long-lasting chlorine dioxide release system aligns perfectly with these trends, offering a scalable solution for continuous environmental sterilization across diverse global markets, from healthcare to public infrastructure.
Enables Power-Free Disinfection Anywhere: Achieves stable, continuous chlorine dioxide gas release without external power, enabling compact, lightweight, and highly portable solutions for flexible installation.
Secures Long-Term Market Exclusivity Until 2041: Provides approximately 14 years of exclusive market advantage until 2041, allowing for stable supply and robust market positioning.
Delivers Reliable Sterilization and Disinfection: Ensures effective sterilization and disinfection against a broad spectrum of microorganisms through a combination of layered double hydroxide with intercalated chlorate ions and a solid reactant.
This patent protects a comprehensive range of forms, including the chlorine dioxide gas sustained-release agent, its packaging, the release method, and the release apparatus, across 21 claims. It was granted after successfully overcoming examiner rejections, demonstrating clear inventiveness over prior art and establishing a robust, difficult-to-invalidate right.
While protecting the core gas release mechanism, this patent leaves white space for integrating the agent into smart monitoring systems or developing advanced material composites for enhanced durability or controlled release profiles.
Assuming a licensee deploys this technology in 100 healthcare or eldercare facilities. Each facility could reduce annual labor costs for daily disinfection by ~$1,500 (AI est.) by optimizing staff time, and reduce annual electricity costs for conventional powered disinfection devices by ~$500 (AI est.). This totals ~$2,000/facility/year (AI est.). Across 100 facilities, this projects to an annual cost reduction of ~$200,000 (AI est.). Further benefits include potential healthcare cost reductions from lower infection rates.
X: Operational Cost Efficiency
Y: Installation Flexibility & Portability